Comparative dementia risk with GLP1 receptor agonists, SGLT2 inhibitors, or DPP4 inhibitors: a population-based cohort study. - Wu CY; Alkabbani W; Shah BR; Kapral MK; Edwards JD; Maxwell CJ; Swardfager W (Alzheimer's research & therapy, 2025)